January 9, 2024 by Jeffrey Woldt
CVS builds a world of health for customers
January 8, 2024, Opinion
Most retailers talk a lot about the customer-centric imperative; CVS Health is doing something about it. In recent years, the company has been on a journey to strengthen the connective tissue uniting the various aspects of the organization, in an effort to provide a seamless experience for patients and consumers — no matter which CVS
January 9, 2024 by Steven Anderson
CEO National Association of Chain Drug Stores, Health care outlook 2024: Steve Anderson President
January 8, 2024, Opinion, Pharmacy
In the first of a two-part series, leaders of industry associations present their expectations for pharmacy operators for this year. The views of other organizations will appear in the next issue of Chain Drug Review. The Good to Great principles of author and consultant Jim Collins — a great friend of NACDS — stand the
January 9, 2024 by David Pinto
A memorable occasion for NACDS, mass retailing
January 8, 2024, Opinion
Viewed from almost any perspective, December 13, 2023, was a significant day in the history of mass retailing in America. On that day, to informally recognize the 90th anniversary of the National Association of Chain Drug Stores, America’s mass retailing community gathered together a not-so-random sampling of the individuals who created, advanced and immortalized health
January 9, 2024 by John O'Brien
John O’Brien, National Pharmaceutical Council, president and CEO
January 22, 2024, Opinion, Pharmacy
In the second of a two-part series, leaders of industry associations present their expectations for pharmacy operators for this year. 2023 was a pivotal year for health policy, to say the least. The swift implementation of the IRA’s Medicare Drug Price Negotiation Program (DPNP) by the Centers for Medicare and Medicaid Services (CMS), the growing
January 9, 2024 by Scott Melville
CHPA, Health care outlook 2024: Scott Melville, president and CEO
January 22, 2024, Opinion, Pharmacy
In the second of a two-part series, leaders of industry associations present their expectations for pharmacy operators for this year. The year 2023 marked another significant milestone for consumer health care with the continued growth of self-care driving the demand for safe and beneficial over-the-counter medicines, dietary supplements and consumer medical devices. Americans are prioritizing
January 9, 2024 by Chip Davis
2024 Health care outlook: Chip Davis, president and CEO HDA
January 22, 2024, Opinion, Pharmacy
In the second of a two-part series, leaders of industry associations present their expectations for pharmacy operators for this year. Health care policy issues will inevitably emerge as a topic of the national debate in the 2024 election season. Access and affordability remain part of the dialogue, and implementation of the Inflation Reduction Act —
January 9, 2024 by Micah Cost
CEO of the Pharmacy Quality Alliance, Health care outlook 2024: Micah Cost
January 22, 2024, Opinion, Pharmacy
In the second of a two-part series, leaders of industry associations present their expectations for pharmacy operators for this year. Former Defense Secretary Donald Rumsfeld once observed that “there are known knowns. There are things we know we know. We also know there are known unknowns. That is to say we know there are some
January 9, 2024 by Ronald Piervincenzi
2024 Health care outlook: Ronald Piervincenzi, CEO, U.S. Pharmacopeia
January 22, 2024, Opinion, Pharmacy
In the second of a two-part series, leaders of industry associations present their expectations for pharmacy operators for this year. The past year was significant for the pharmaceutical industry, as we witnessed major milestones and celebrated advancements in innovation. We saw an official end to the COVID-19 pandemic public health emergency and unlocked the potential
January 8, 2024 by Jeffrey Woldt
Walmart saluted as Health Care Provider of the Year
Featured Articles, January 8, 2024, Leading Headlines, Retail News
BENTONVILLE, Ark. — In the realm of health and wellness, the endpoint is where Walmart begins. After first gaining a thorough understanding of patients, customers and their needs, the company has set out to construct a dynamic ecosystem that promises to transform the way in which Americans get and stay well. In light of the
January 8, 2024 by Chain Drug Review
Brad Cochran, Claire Biermass, Jeff Leger, Jennifer Zilka, Prem Shah, Retail Forecast 2024, Scott Miller, Todd Gustin, Tracey Brown
Business, January 8, 2024, Leading Headlines, Retail News
Leading chain drug and distribution executives provide their outlook for the coming year on the following pages, spelling out the challenges and opportunities that lie ahead for their companies and the industry. Prem Shah Executive Vice President, Chief Pharmacy Officer and President, Pharmacy and Consumer Wellness, CVS Health The need for accessible and affordable care
January 8, 2024 by Sheila Arquette
Health care outlook 2024: Sheila Arquette President and CEO, National Association of Specialty Pharmacy
January 8, 2024, Opinion, Pharmacy
In the first of a two-part series, leaders of industry associations present their expectations for pharmacy operators for this year. The views of other organizations will appear in the next issue of Chain Drug Review. Specialty pharmacy continues to be dynamic, demanding and disruptive. As the market continues to demand specialization in drug distribution and
January 8, 2024 by Sandra Hanna
CEO, Health care outlook 2024: Sandra Hanna, Neighbourhood Pharmacies
January 8, 2024, Opinion, Pharmacy
In the first of a two-part series, leaders of industry associations present their expectations for pharmacy operators for this year. The views of other organizations will appear in the next issue of Chain Drug Review. 2023 was a momentous year for community pharmacy in Canada. All provinces further expanded pharmacists’ scope of practice and/or increased
January 8, 2024 by B. Douglas Hoey
Health care outlook 2024: B. Douglas Hoey CEO, National Community Pharmacists Association
January 8, 2024, Opinion, Pharmacy
In the first of a two-part series, leaders of industry associations present their expectations for pharmacy operators for this year. The views of other organizations will appear in the next issue of Chain Drug Review. The date January 1 can have varying meanings for people. It’s the first day of a new year, of course.
January 8, 2024 by Lee Ann Stember
CEO, Lee Ann Stember, NCPDP, president
January 8, 2024, Opinion, Pharmacy
In the first of a two-part series, leaders of industry associations present their expectations for pharmacy operators for this year. The views of other organizations will appear in the next issue of Chain Drug Review We are, without a doubt, at a tipping point with the current state of pharmacy practice. Drug shortages, staffing shortages,